 reason lack benefit immedi angioplasti recombin tissu plasminogen activ therapi acut myocardi infarct region wall motion analysi european cooper studi group region ventricular wall motion analysi util differ method predischarg ventriculogram patient random trial singl chain recombin tissue-typ plasminogen activ rt-pa aspirin heparin immedi angioplasti patient acut myocardi infarct univari analysi differ region wall motion variabl treatment group individu baselin risk assess multivari linear regress analysi baselin characterist ventricular function thrombolyt therapi outcom coronari angioplasti excess high risk patient invas treatment group unequ distribut baselin risk linear regress analysi benefit immedi coronari angioplasti adjust reocclus reinfarct invas noninvas treatment group patient patent infarct-rel vessel angiographi day reinfarct angiographi trend benefit invas strategi reocclus reinfarct respons lack benefit invas strategi immedi coronari angioplasti benefici select patient complic